Research on the Quality of Cancer Care in Diverse Populations
  • National Cancer Institute: The Challenges of Individualizing Treatments for Breast Cancer. (P01 CA163233, P.I. Steven Katz, MD, MPH) The overall goal of this Program is to improve population health by helping clinicians and their patients address the challenges of individualizing treatment of breast cancer for patients with favorable prognosis. To do this we will harness the energy of a seasoned interdisciplinary research team to achieve four main objectives: Objective 1: To examine the challenges of individualizing treatment for women newly diagnosed with breast cancer. Two program projects will undertake a population-based observational study sharing 4600 patients newly diagnosed with breast cancer (including their attending clinicians), who were reported to the SEER registries in Georgia and Los Angeles County during an 18 month period, to examine patient and clinician factors associated with key evaluative tests, treatments, and patient appraisal of decision quality. Objective 2: To improve decision quality for patients with newly diagnosed breast cancer by performing a randomized controlled trial of a surgeon practice-based online tailored treatment decision tool for patients newly diagnosed with breast cancer in the Detroit and Atlanta metropolitan SEER catchment areas. Objective 3: To accelerate the dissemination of SEER-based research findings to clinicians in the region by developing, implementing, and evaluating a tailored web portal to all attending surgeons and medical oncologists of the patients to evaluate whether our research findings can more directly and promptly inform clinicians’ knowledge and attitudes about individualizing treatment. Objective 4: To advance methods in SEER population translational research focused on quality of cancer care. The goals and objectives of the proposed program will have a sustained impact on the field by evaluating a compelling conceptual framework salient to patients and their physicians, informing and improving communication and decision-making for patients with breast cancer, and advancing innovative methods in population-based oncology outcomes research.
  • << Back